Nasim Sobhani, MD

Principal Investigator
Maternal Fetal Medicine

Dr. Nasim Sobhani is a perinatologist, an obstetrician who specializes in care during high-risk pregnancies. She provides comprehensive care for women with preexisting conditions that can affect pregnancy and for women with pregnancy-specific health conditions. She also cares for developing fetuses when genetic or structural conditions have been diagnosed in utero. She sees patients in both the hospital and the clinic.

Dr. Sobhani serves as the medical director of the Endocrine, Diabetes, and Pregnancy Program, which is responsible for overseeing the care of all pregnant individuals with pre-existing and gestational diabetes at UCSF. As the most common medical complication of pregnancy, diabetes contributes to significant increases in the risk of adverse maternal, obstetric, and neonatal outcomes. Thoughtful clinical research is needed to optimize the care of pregnant people living with diabetes. Dr. Sobhani’s research efforts examine how to diagnose and manage gestational diabetes; how to improve perinatal outcomes for pregnancies with type 1 and type 2 diabetes; and how to leverage emerging diabetes technology in the pregnant population.

Dr. Sobhani earned her medical degree at the University of Texas Southwestern Medical School. She completed a residency in obstetrics and gynecology at the University of Washington, followed by a fellowship in maternal-fetal medicine at UCSF.

Featured Publications: 

Use of a Commercially Available Automated Insulin Delivery System for the Management of Type 1 Diabetes in Pregnancy.

Journal of diabetes science and technology

Sobhani NC, Han CS, Sarker MR, Shah S, Ramos GA

Use of Open-Source Automated Insulin Delivery Systems in Pregnancies With Type 1 Diabetes.

Journal of diabetes science and technology

Sobhani NC, Killion M, Patzek S

Continuous glucose monitoring in pregnancies with type 1 diabetes: small increases in time-in-range improve maternal and perinatal outcomes.

American journal of obstetrics and gynecology

Sobhani NC, Goemans S, Nguyen A, Chambers ME, Richley M, Gabby LC, Field N, Han CS, Ramos GA

Method of insulin delivery does not affect perinatal outcomes with type 1 diabetes mellitus.

American journal of obstetrics & gynecology MFM

Sobhani NC, Watson K, Kannan A, Patzek S

Diabetic Ketoacidosis and Adverse Outcomes Among Pregnant Individuals With Pregestational Diabetes in the United States, 2010-2020.

Obstetrics and gynecology

Wen T, Friedman AM, Gyamfi-Bannerman C, Powe CE, Sobhani NC, Ramos GA, Gabbe S, Landon MB, Grobman WA, Venkatesh KK

1